Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niven Mehra

Showing results (11-20 of 161) with videos related to

Pageof 17
Sort By:
Clinical Pharmacokinetics|July 17, 2023
Clinical Pharmacokinetics and Pharmacodynamics of the Next Generation Androgen Receptor Inhibitor-DarolutamideEva Podgoršek, Niven Mehra, Inge M van Oort, et al.
BJU International|November 6, 2021
Prognostic importance of concomitant non-regional lymph node and bone metastases in men with newly diagnosed metastatic prostate cancerBerdine L Heesterman, Henk G van der Poel, Ivo G Schoots, et al.
Experimental Cell Research|November 9, 2004
The von Hippel-Lindau tumor suppressor protein influences microtubule dynamics at the cell peripheryMartijn P Lolkema, Niven Mehra, Anita S Jorna, et al.
British Journal of Clinical Pharmacology|February 1, 2018
A clinically relevant decrease in abiraterone exposure associated with carbamazepine use in a patient with castration-resistant metastatic prostate cancerGuillemette E Benoist, Maarten J van der Doelen, Rob Ter Heine, et al.
BJUI Compass|April 27, 2022
M1a prostate cancer: Results of a Dutch multidisciplinary consensus meetingShafak Aluwini, Daniela E Oprea-Lager, Hilda de Barros, et al.
Cancer Letters|August 26, 2004
Circulating endothelial cells in cancer patients do not express tissue factorLaurens V Beerepoot, Niven Mehra, Frank Linschoten, et al.
Clinical Genitourinary Cancer|June 14, 2017
Neutrophil to Lymphocyte Ratio in Castration-Resistant Prostate Cancer Patients Treated With Daily Oral CorticosteroidsNiven Mehra, Adam Sharp, David Lorente, et al.
International Journal of Molecular Sciences|May 27, 2023
Transcriptome Profiling of Circulating Tumor Cells to Predict Clinical Outcomes in Metastatic Castration-Resistant Prostate CancerLevi Groen, Iris Kloots, David Englert, et al.
Clinical Genitourinary Cancer|December 19, 2018
Patient Selection for Radium-223 Therapy in Patients With Bone Metastatic Castration-Resistant Prostate Cancer: New Recommendations and Future PerspectivesMaarten J van der Doelen, Niven Mehra, Rick Hermsen, et al.
EJNMMI Physics|April 3, 2024
Bone marrow dosimetry in low volume mHSPC patients receiving Lu-177-PSMA therapy using SPECT/CTDagmar Grob, Bastiaan M Privé, Constantijn H J Muselaers, et al.
Pageof 17

Showing results (11-20 of 161) with videos related to

Sort By:
Pageof 17
Clinical Pharmacokinetics|July 17, 2023
Clinical Pharmacokinetics and Pharmacodynamics of the Next Generation Androgen Receptor Inhibitor-DarolutamideEva Podgoršek, Niven Mehra, Inge M van Oort, et al.
BJU International|November 6, 2021
Prognostic importance of concomitant non-regional lymph node and bone metastases in men with newly diagnosed metastatic prostate cancerBerdine L Heesterman, Henk G van der Poel, Ivo G Schoots, et al.
Experimental Cell Research|November 9, 2004
The von Hippel-Lindau tumor suppressor protein influences microtubule dynamics at the cell peripheryMartijn P Lolkema, Niven Mehra, Anita S Jorna, et al.
British Journal of Clinical Pharmacology|February 1, 2018
A clinically relevant decrease in abiraterone exposure associated with carbamazepine use in a patient with castration-resistant metastatic prostate cancerGuillemette E Benoist, Maarten J van der Doelen, Rob Ter Heine, et al.
BJUI Compass|April 27, 2022
M1a prostate cancer: Results of a Dutch multidisciplinary consensus meetingShafak Aluwini, Daniela E Oprea-Lager, Hilda de Barros, et al.
Cancer Letters|August 26, 2004
Circulating endothelial cells in cancer patients do not express tissue factorLaurens V Beerepoot, Niven Mehra, Frank Linschoten, et al.
Clinical Genitourinary Cancer|June 14, 2017
Neutrophil to Lymphocyte Ratio in Castration-Resistant Prostate Cancer Patients Treated With Daily Oral CorticosteroidsNiven Mehra, Adam Sharp, David Lorente, et al.
International Journal of Molecular Sciences|May 27, 2023
Transcriptome Profiling of Circulating Tumor Cells to Predict Clinical Outcomes in Metastatic Castration-Resistant Prostate CancerLevi Groen, Iris Kloots, David Englert, et al.
Clinical Genitourinary Cancer|December 19, 2018
Patient Selection for Radium-223 Therapy in Patients With Bone Metastatic Castration-Resistant Prostate Cancer: New Recommendations and Future PerspectivesMaarten J van der Doelen, Niven Mehra, Rick Hermsen, et al.
EJNMMI Physics|April 3, 2024
Bone marrow dosimetry in low volume mHSPC patients receiving Lu-177-PSMA therapy using SPECT/CTDagmar Grob, Bastiaan M Privé, Constantijn H J Muselaers, et al.
Pageof 17